TP53 and breast carcinoma: TCGA data analysis revealed that deregulation in TP53 expression is significantly correlated with breast cancer stages which may be due to mutations in TP53 gene and/or due to the overexpression of MDM2 which targets TP53 to proteasomal degradation.